These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39086819)
1. Ruthenium(II) complexes of curcumin and β-diketone derivatives: effect of structural modifications on their cytotoxicity. Jacinto FE; de Oliveira LP; Batista AA; Oliveira KM; Correa RS R Soc Open Sci; 2024 Jul; 11(7):240353. PubMed ID: 39086819 [TBL] [Abstract][Full Text] [Related]
5. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation. Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661 [TBL] [Abstract][Full Text] [Related]
6. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7). Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726 [TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction. Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499 [TBL] [Abstract][Full Text] [Related]
8. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents. Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686 [TBL] [Abstract][Full Text] [Related]
9. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo. da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA. Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415 [TBL] [Abstract][Full Text] [Related]
17. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion. Xie L; Wang L; Guan R; Ji L; Chao H J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250 [TBL] [Abstract][Full Text] [Related]
18. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144 [TBL] [Abstract][Full Text] [Related]
19. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497 [TBL] [Abstract][Full Text] [Related]
20. Heterocyclic (pyrazine)carboxamide Ru(ii) complexes: structural, experimental and theoretical studies of interactions with biomolecules and cytotoxicity. Tsaulwayo N; Omondi RO; Vijayan P; Sibuyi NRS; Meyer MD; Meyer M; Ojwach SO RSC Adv; 2024 Mar; 14(12):8322-8330. PubMed ID: 38567259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]